Read More Pharma Industry News Eupraxia Pharmaceuticals announces promising results for EP-104GI in eosinophilic esophagitis trial Eupraxia Pharmaceuticals Inc., listed on both TSX and NASDAQ under the ticker EPRX, has revealed encouraging results from… byPallavi MadhirajuMay 22, 2024